<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is the most common cardiac rhythm disorder and places a substantial burden on the US healthcare system </plain></SENT>
<SENT sid="1" pm="."><plain>Unfortunately, there is no consensus as to whether patients should be treated with a primary rate- or rhythm-control strategy </plain></SENT>
<SENT sid="2" pm="."><plain>The use of anti-arrhythmic drugs in the treatment of AF is discussed in the broader context of AF disease-management strategies with a focus on rhythm control </plain></SENT>
<SENT sid="3" pm="."><plain>Outside of rhythm/ECG, AF treatment targets and cardiovascular outcomes are highlighted </plain></SENT>
</text></document>